| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $75.8M | -46.3% |
| Cost of Revenue | $62.5M | -29.8% |
| Gross Profit | $13.3M | -74.4% |
| R&D Expense | $12.1M | -13.2% |
| SG&A Expense | $22.8M | -11.1% |
| Operating Income | -$21.6M | -271.8% |
| Pre-tax Income | -$19.0M | -190.9% |
| Income Tax | $160K | -92.7% |
| Net Income | -$17.9M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.8M | +8.0% |
| Short-term Investments | $2.1M | -77.1% |
| Accounts Receivable | $19.3M | -34.2% |
| Inventory | $86.5M | -3.5% |
| Current Assets | $170.7M | -7.0% |
| Total Assets | $358.7M | -3.1% |
| Current Liabilities | $81.6M | +8.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.4M | +138.8% |
| Capital Expenditures | $10.5M | -63.2% |
| Investing Cash Flow | -$2.6M | +89.7% |
| Financing Cash Flow | $8.6M | -77.4% |
| Free Cash Flow | -$7.1M | +81.0% |
| -213.1% |
| EPS (Basic) | -$0.42 | -213.5% |
| EPS (Diluted) | -$0.42 | -213.5% |
| Total Liabilities |
| $89.6M |
| +11.5% |
| Stockholders' Equity | $204.0M | -8.0% |